Nemes Rush Group LLC Fulgent Genetics, Inc. Transaction History

Nemes Rush Group LLC

$689 Billion
Q3 2024

A detailed history of Nemes Rush Group LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Nemes Rush Group LLC holds 13 shares of FLGT stock, worth $232. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$232

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$19.6 - $25.06 $254 - $325	13 New	13 $282,000
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $280 - $380	13 New	13 $283,000

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

Black Rock Inc. New York, NY

3.92M
Shares

$70.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.45M
Shares

$25.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.27M
Shares

$22.7 Million
0.01% of portfolio
Dimensional Fund Advisors LP Austin, TX

1.11M
Shares

$19.8 Million
0.01% of portfolio
State Street Corp Boston, MA

794K
Shares

$14.2 Million
0.0% of portfolio

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $541M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.

Account